Definitive Contract 75A50124C00055
Award Date
9/30/24
Potential Completion Date
2/24/28
Potential Value
$9.4M
Awardee
Sherlock Biosciences, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Sharing
Place of Performance
East Watertown, MA 02472, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $34,714,763.00 cost-plus-fixed-fee contract was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Detect Inc. to advance the development of a second-generation, multi-analyte molecular SARS-CoV-2 and influenza A/B test that has a reduced time to result and increased sensitivity for use at home or in a point-of-care setting. The contract is not set aside. The award references a Broad Agency Announcement (BAA) issued by the Biomedical Advanced Research...
This is a $24,631,080.00 definitive, cost-no-fee contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS) to Sapphiros LLC, a for-profit foreign-owned company based in Boston, Massachusetts. The contract is for the advanced research and development of a low-cost, connected, digital lateral flow platform to detect Influenza A, Influenza B, and SARS-CoV-2 for use in over-the-counter (OTC)...
The U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, awarded a $508,865.04 firm-fixed price contract to the J. David Gladstone Institutes, a non-profit biomedical research organization in San Francisco, California. The contract is for research and development to multiplex CRISPR-Cas13A technology for an at-home viral diagnostic, in support of the agency's efforts to enable home-based diagnostics for SARS-CoV-2 acute infection. This...
This is a $38,900,000.00 firm fixed-price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Hologic, Inc. to ensure test availability for SARS-CoV-2 after the emergency authorization closes. The purpose is for Hologic to submit an in vitro diagnostic (IVD) assay for SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV) by September 30, 2027. This contract was awarded under a Broad Agency Announcement (BAA)...
The U.S. Department of Health and Human Services (HHS), Office of the Assistant Secretary for Preparedness and Response, awarded a $740,000.00 definitive, firm-fixed-price contract to Jumpcode Genomics Inc. for CRISPR-powered next-generation sequencing (NGS)-based agnostic diagnostic capabilities under the Division of Research, Innovation, and Ventures (DRIVe) Easy Broad Agency Announcement (EZ-BAA). This contract, which has a period of performance through September 25, 2023, was awarded on a...
<p>This is a $243,500.00 firm fixed-price Definitive Contract awarded by the Centers for Disease Control and Prevention (CDC) to Innotech Precision Medicine, Inc., a woman-owned small business, for the Phase I development of the SHERLOCK assay under the NCEZID TOPIC 031 program. The contract has a total small business set-aside designation and an ultimate completion date of March 9, 2025. The place of performance is Atlanta, Georgia.</p>
This federal contract award, valued at $113,182,532.15, was issued by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract supports ASPR's efforts to develop medical countermeasures against chemical, biological, radiological, nuclear (CBRN) threats and pandemic influenza under the Pandemic and All Hazard Preparedness Act. The contract aims to establish a platform for the diagnosis and...
This is a federal contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Pattern Bioscience, Inc., a biotechnology company, to develop a rapid pathogen identification and antimicrobial susceptibility testing platform. The contract, valued at $40,937,536.73, is for the verification, clinical evaluation, and U.S. Food and Drug Administration (FDA) clearance of this culture-free, phenotypic diagnostic platform. The contract is a...
This is a $2,100,000.00 Firm Fixed Price (FFP) contract awarded by the U.S. Department of Health and Human Services (HHS), Administration for Strategic Preparedness and Response (ASPR), Center for Industrial Base Expansion and Supply Chain (IBMSC) to Osang LLC, a small disadvantaged business, for the delivery of 1,000,000 commercial off-the-shelf multi-antigen diagnostic test kits capable of detecting SARS-CoV-2 and Influenza A/B. The contract has a 12-month period of performance and is a 100%...
This is a $52,239,640.00 definitive contract awarded to Visby Medical, Inc. by the U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response. The contract is for the delivery of a rapid, accurate, point-of-care disposable influenza and SARS-CoV-2 molecular diagnostic test. This award is not set aside for any particular business classification. The contract has an ultimate completion date of March 31, 2026. The original solicitation was issued...